ID: ALA4068198

Max Phase: Preclinical

Molecular Formula: C21H24N2

Molecular Weight: 304.44

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(CNC2CCc3c(n(C)c4ccccc34)C2)cc1

Standard InChI:  InChI=1S/C21H24N2/c1-15-7-9-16(10-8-15)14-22-17-11-12-19-18-5-3-4-6-20(18)23(2)21(19)13-17/h3-10,17,22H,11-14H2,1-2H3

Standard InChI Key:  SHRJKINVHLWHRC-UHFFFAOYSA-N

Associated Targets(Human)

Retinoblastoma-associated protein 82 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 304.44Molecular Weight (Monoisotopic): 304.1939AlogP: 4.13#Rotatable Bonds: 3
Polar Surface Area: 16.96Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.68CX LogP: 4.62CX LogD: 2.38
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.77Np Likeness Score: -0.64

References

1. Kulkarni MR, Mane MS, Ghosh U, Sharma R, Lad NP, Srivastava A, Kulkarni-Almeida A, Kharkar PS, Khedkar VM, Pandit SS..  (2017)  Discovery of tetrahydrocarbazoles as dual pERK and pRb inhibitors.,  134  [PMID:28431342] [10.1016/j.ejmech.2017.02.062]

Source